_id
6915f258bc934aba376b2147
Ticker
RXEI
Name
RxElite Inc
Exchange
OTCCE
Address
1404 North Main, Meridian, ID, United States, 83642
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.piramalcriticalcare.com
Description
RxElite, Inc. engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets. Its products include Sterile Liquid Dose products that consist of generic ophthalmic products in unit and multi-dose presentations, sterile unit dose inhalation respiratory products, and injectable drugs. The company, through its subsidiaries, also manufactures active pharmaceutical ingredients for pharmaceutical companies in the United States, Europe, and Asia. Its customers include hospitals and hospital group purchasing organizations, national and regional wholesalers, direct retail pharmacy stocking chains, homecare companies, and outpatient surgery centers and ambulatory care clinics. The company has partnership agreements with Stason Pharmaceuticals, Inc.; Alkem Laboratories Limited; and Zach Systems S.p.A. RxElite is headquartered in Meridian, Idaho. RxElite Inc. operates as a subsidiary of Piramal Healthcare Ltd.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-06T10:37:07.690Z
Image
-
Ipo Date
-
Market Cap
35912
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2008-09-30
Revenue
3257718
Cost Of Revenue
2951207
Gross Profit
306511
Operating Expenses
6412914
Operating Income
-3155196
Interest Expense
1885775
Pretax Income
-10965762
Net Income
-10965762
Eps
-
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
0
EBITDA
-
Operating Margin
-96.8529504395408
Total Other Income Expense Net
-7810566
Cash
1348216
Short Term Investments
-
Receivables
992814
Inventories
5172498
Total Current Assets
8315839
Property Plant Equipment
7823349
Total Assets
33029092
Payables
7794452
Short Term Debt
7106886
Long Term Debt
6932514
Total Liabilities
18958181
Equity
14070911
Bs_currency_symbol
USD
Depreciation
708936
Change In Working Capital
-
Cash From Operations
-1073826
Capital Expenditures
101738
Cash From Investing
-101738
Cash From Financing
-131057
Net Change In Cash
-1306621
Cf_currency_symbol
USD
PE
-
PB
-
ROE
-77.93213957504244
ROA
-33.200313226897066
FCF
-1175564
Fcf Percent
-0.36085505252449723
Piotroski FScore
1
Health Score
26
Deep Value Investing Score
2.5
Defensive Investing Score
4.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
1.5
Quarters > 0 > quarter
2008-09-30
Quarters > 0 > income Statement > revenue
3257718
Quarters > 0 > income Statement > cost Of Revenue
2951207
Quarters > 0 > income Statement > gross Profit
306511
Quarters > 0 > income Statement > operating Expenses
6412914
Quarters > 0 > income Statement > operating Income
-3155196
Quarters > 0 > income Statement > interest Expense
1885775
Quarters > 0 > income Statement > pretax Income
-10965762
Quarters > 0 > income Statement > net Income
-10965762
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-96.8529504395408
Quarters > 0 > income Statement > total Other Income Expense Net
-7810566
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1348216
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
992814
Quarters > 0 > balance Sheet > inventories
5172498
Quarters > 0 > balance Sheet > total Current Assets
8315839
Quarters > 0 > balance Sheet > property Plant Equipment
7823349
Quarters > 0 > balance Sheet > total Assets
33029092
Quarters > 0 > balance Sheet > payables
7794452
Quarters > 0 > balance Sheet > short Term Debt
7106886
Quarters > 0 > balance Sheet > long Term Debt
6932514
Quarters > 0 > balance Sheet > total Liabilities
18958181
Quarters > 0 > balance Sheet > equity
14070911
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-10965762
Quarters > 0 > cash Flow > depreciation
708936
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-1073826
Quarters > 0 > cash Flow > capital Expenditures
101738
Quarters > 0 > cash Flow > cash From Investing
-101738
Quarters > 0 > cash Flow > cash From Financing
-131057
Quarters > 0 > cash Flow > net Change In Cash
-1306621
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-77.93213957504244
Quarters > 0 > ratios > ROA
-33.200313226897066
Quarters > 0 > ratios > FCF
-1175564
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.36085505252449723
Quarters > 0 > health Score
26
Quarters > 1 > quarter
2008-06-30
Quarters > 1 > income Statement > revenue
3006036
Quarters > 1 > income Statement > cost Of Revenue
2503315
Quarters > 1 > income Statement > gross Profit
502721
Quarters > 1 > income Statement > operating Expenses
6079809
Quarters > 1 > income Statement > operating Income
-3073773
Quarters > 1 > income Statement > interest Expense
1865370
Quarters > 1 > income Statement > pretax Income
-6389599
Quarters > 1 > income Statement > net Income
-6389599
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-102.25336622715098
Quarters > 1 > income Statement > total Other Income Expense Net
-3315826
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2654837
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1788078
Quarters > 1 > balance Sheet > inventories
9549396
Quarters > 1 > balance Sheet > total Current Assets
14687909
Quarters > 1 > balance Sheet > property Plant Equipment
6877935
Quarters > 1 > balance Sheet > total Assets
38525958
Quarters > 1 > balance Sheet > payables
10629478
Quarters > 1 > balance Sheet > short Term Debt
5806793
Quarters > 1 > balance Sheet > long Term Debt
2619017
Quarters > 1 > balance Sheet > total Liabilities
20138492
Quarters > 1 > balance Sheet > equity
18387466
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6389599
Quarters > 1 > cash Flow > depreciation
562187
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-1673382
Quarters > 1 > cash Flow > capital Expenditures
161297
Quarters > 1 > cash Flow > cash From Investing
347797
Quarters > 1 > cash Flow > cash From Financing
2899374
Quarters > 1 > cash Flow > net Change In Cash
1573789
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-34.749752902330314
Quarters > 1 > ratios > ROA
-16.585178751427804
Quarters > 1 > ratios > FCF
-1834679
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.610331679327859
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2008-03-31
Quarters > 2 > income Statement > revenue
2999403
Quarters > 2 > income Statement > cost Of Revenue
2642142
Quarters > 2 > income Statement > gross Profit
357261
Quarters > 2 > income Statement > operating Expenses
5473185
Quarters > 2 > income Statement > operating Income
-2473782
Quarters > 2 > income Statement > interest Expense
1616067
Quarters > 2 > income Statement > pretax Income
-7039840
Quarters > 2 > income Statement > net Income
-7039840
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-82.47581268672465
Quarters > 2 > income Statement > total Other Income Expense Net
-4566058
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1081048
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2438924
Quarters > 2 > balance Sheet > inventories
9658516
Quarters > 2 > balance Sheet > total Current Assets
14132023
Quarters > 2 > balance Sheet > property Plant Equipment
6201377
Quarters > 2 > balance Sheet > total Assets
37410098
Quarters > 2 > balance Sheet > payables
9262073
Quarters > 2 > balance Sheet > short Term Debt
1495987
Quarters > 2 > balance Sheet > long Term Debt
1305519
Quarters > 2 > balance Sheet > total Liabilities
14413742
Quarters > 2 > balance Sheet > equity
22996356
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-7039840
Quarters > 2 > cash Flow > depreciation
469240
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-2006853
Quarters > 2 > cash Flow > capital Expenditures
6763393
Quarters > 2 > cash Flow > cash From Investing
-6949893
Quarters > 2 > cash Flow > cash From Financing
-75790
Quarters > 2 > cash Flow > net Change In Cash
-9032536
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-30.612850140257002
Quarters > 2 > ratios > ROA
-18.81802073867863
Quarters > 2 > ratios > FCF
-8770246
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-2.9239972087778803
Quarters > 2 > health Score
32
Quarters > 3 > quarter
2007-12-31
Quarters > 3 > income Statement > revenue
1175161
Quarters > 3 > income Statement > cost Of Revenue
1344651
Quarters > 3 > income Statement > gross Profit
-169490
Quarters > 3 > income Statement > operating Expenses
5999534
Quarters > 3 > income Statement > operating Income
-4824373
Quarters > 3 > income Statement > interest Expense
88496
Quarters > 3 > income Statement > pretax Income
-4839741
Quarters > 3 > income Statement > net Income
-4839741
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-410.52868500571407
Quarters > 3 > income Statement > total Other Income Expense Net
-15368
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
10113584
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
969085
Quarters > 3 > balance Sheet > inventories
7353339
Quarters > 3 > balance Sheet > total Current Assets
18530280
Quarters > 3 > balance Sheet > property Plant Equipment
1832573
Quarters > 3 > balance Sheet > total Assets
21266365
Quarters > 3 > balance Sheet > payables
5720737
Quarters > 3 > balance Sheet > short Term Debt
256185
Quarters > 3 > balance Sheet > long Term Debt
55848
Quarters > 3 > balance Sheet > total Liabilities
8959570
Quarters > 3 > balance Sheet > equity
12306795
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-4839741
Quarters > 3 > cash Flow > depreciation
237734
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
862166
Quarters > 3 > cash Flow > capital Expenditures
1157241
Quarters > 3 > cash Flow > cash From Investing
-1157241
Quarters > 3 > cash Flow > cash From Financing
10009595
Quarters > 3 > cash Flow > net Change In Cash
9714520
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-39.32576271888822
Quarters > 3 > ratios > ROA
-22.757725638584684
Quarters > 3 > ratios > FCF
-295075
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.2510932544561979
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2007-12-31
Annuals > 0 > income Statement > revenue
2811596
Annuals > 0 > income Statement > cost Of Revenue
2667596
Annuals > 0 > income Statement > gross Profit
144000
Annuals > 0 > income Statement > operating Expenses
15092570
Annuals > 0 > income Statement > operating Income
-12280974
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-17165275
Annuals > 0 > income Statement > net Income
-17165275
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-436.79724967598474
Annuals > 0 > income Statement > total Other Income Expense Net
-4884301
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
10113584
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
969085
Annuals > 0 > balance Sheet > inventories
7353339
Annuals > 0 > balance Sheet > total Current Assets
18530280
Annuals > 0 > balance Sheet > property Plant Equipment
1832573
Annuals > 0 > balance Sheet > total Assets
21266365
Annuals > 0 > balance Sheet > payables
5720737
Annuals > 0 > balance Sheet > short Term Debt
256185
Annuals > 0 > balance Sheet > long Term Debt
55848
Annuals > 0 > balance Sheet > total Liabilities
8959570
Annuals > 0 > balance Sheet > equity
12306795
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-17165275
Annuals > 0 > cash Flow > depreciation
436967
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-13366194
Annuals > 0 > cash Flow > capital Expenditures
1847239
Annuals > 0 > cash Flow > cash From Investing
-1847239
Annuals > 0 > cash Flow > cash From Financing
22923873
Annuals > 0 > cash Flow > net Change In Cash
7710440
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-139.4780281949931
Annuals > 0 > ratios > ROA
-80.715604194699
Annuals > 0 > ratios > FCF
-15213433
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-5.410959824953514
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2006-12-31
Annuals > 1 > income Statement > revenue
14171134
Annuals > 1 > income Statement > cost Of Revenue
13870372
Annuals > 1 > income Statement > gross Profit
300762
Annuals > 1 > income Statement > operating Expenses
18435533
Annuals > 1 > income Statement > operating Income
-4264399
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
7525831
Annuals > 1 > income Statement > net Income
7525831
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-30.0921507057939
Annuals > 1 > income Statement > total Other Income Expense Net
11790230
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2403144
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
104402
Annuals > 1 > balance Sheet > inventories
5707510
Annuals > 1 > balance Sheet > total Current Assets
8317434
Annuals > 1 > balance Sheet > property Plant Equipment
331196
Annuals > 1 > balance Sheet > total Assets
8778439
Annuals > 1 > balance Sheet > payables
5535752
Annuals > 1 > balance Sheet > short Term Debt
91386
Annuals > 1 > balance Sheet > long Term Debt
766098
Annuals > 1 > balance Sheet > total Liabilities
7516217
Annuals > 1 > balance Sheet > equity
1262222
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
7525831
Annuals > 1 > cash Flow > depreciation
93728
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-3679005
Annuals > 1 > cash Flow > capital Expenditures
300302
Annuals > 1 > cash Flow > cash From Investing
-300302
Annuals > 1 > cash Flow > cash From Financing
4751966
Annuals > 1 > cash Flow > net Change In Cash
772659
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
596.2367158867457
Annuals > 1 > ratios > ROA
85.73085716036758
Annuals > 1 > ratios > FCF
-3979307
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.2808037098513076
Annuals > 1 > health Score
44
Annuals > 2 > quarter
2005-12-31
Annuals > 2 > income Statement > revenue
25628628
Annuals > 2 > income Statement > cost Of Revenue
24261326
Annuals > 2 > income Statement > gross Profit
1367302
Annuals > 2 > income Statement > operating Expenses
26646573
Annuals > 2 > income Statement > operating Income
-1017945
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-437963
Annuals > 2 > income Statement > net Income
-437963
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-3.9719059483012513
Annuals > 2 > income Statement > total Other Income Expense Net
579982
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
239356
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
4602756
Annuals > 2 > balance Sheet > inventories
4167266
Annuals > 2 > balance Sheet > total Current Assets
10532335
Annuals > 2 > balance Sheet > property Plant Equipment
94133
Annuals > 2 > balance Sheet > total Assets
10698866
Annuals > 2 > balance Sheet > payables
788877
Annuals > 2 > balance Sheet > short Term Debt
6816716
Annuals > 2 > balance Sheet > long Term Debt
10752612
Annuals > 2 > balance Sheet > total Liabilities
23008084
Annuals > 2 > balance Sheet > equity
-12330803
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-437963
Annuals > 2 > cash Flow > depreciation
45282
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
315377
Annuals > 2 > cash Flow > capital Expenditures
56091
Annuals > 2 > cash Flow > cash From Investing
-56091
Annuals > 2 > cash Flow > cash From Financing
1371199
Annuals > 2 > cash Flow > net Change In Cash
1630485
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
3.5517800422243386
Annuals > 2 > ratios > ROA
-4.093545988892655
Annuals > 2 > ratios > FCF
259286
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.010117045672519028
Annuals > 2 > health Score
28
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
-77.93213957504244
Profitability > metrics > ROA
-131.86597287417422
Profitability > metrics > Net Margin
-3.3660869357016168
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.34733145565344
Risk > metrics > Interest Coverage
-1.6731561294428021
Risk > final Score
23
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.5580598869712237
Liquidity > metrics > Quick Ratio
0.21094354077466063
Liquidity > final Score
21
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
23
Prev Risks > 1
42
Prev Risks > 2
-170
Prev Liquidities > 0
26
Prev Liquidities > 1
54
Prev Liquidities > 2
100
Updated At
2026-01-20T22:30:54.107Z
RxElite, Inc. engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets. Its products include Sterile Liquid Dose products that consist of generic ophthalmic products in unit and multi-dose presentations, sterile unit dose inhalation respiratory products, and injectable drugs. The company, through its subsidiaries, also manufactures active pharmaceutical ingredients for pharmaceutical companies in the United States, Europe, and Asia. Its customers include hospitals and hospital group purchasing organizations, national and regional wholesalers, direct retail pharmacy stocking chains, homecare companies, and outpatient surgery centers and ambulatory care clinics. The company has partnership agreements with Stason Pharmaceuticals, Inc.; Alkem Laboratories Limited; and Zach Systems S.p.A. RxElite is headquartered in Meridian, Idaho. RxElite Inc. operates as a subsidiary of Piramal Healthcare Ltd.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2008-09-30)
Health Score
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of RxElite Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2008-09-30)
(Last Updated 2008-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2008-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2008-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.